» Articles » PMID: 37918563

What Strengthens Protein-Protein Interactions: Analysis and Applications of Residue Correlation Networks

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2023 Nov 2
PMID 37918563
Authors
Affiliations
Soon will be listed here.
Abstract

Identifying residues critical to protein-protein binding and efficient design of stable and specific protein binders are challenging tasks. Extending beyond the direct contacts in a protein-protein binding interface, our study employs computational modeling to reveal the essential network of residue interactions and dihedral angle correlations critical in protein-protein recognition. We hypothesized that mutating residues exhibiting highly correlated dynamic motion within the interaction network could efficiently optimize protein-protein interactions to create tight and selective protein binders. We tested this hypothesis using the ubiquitin (Ub) and MERS coronaviral papain-like protease (PLpro) complex, since Ub is a central player in multiple cellular functions and PLpro is an antiviral drug target. Our designed ubiquitin variant (UbV) hosting three mutated residues displayed a ∼3,500-fold increase in functional inhibition relative to wild-type Ub. Further optimization of two C-terminal residues within the Ub network resulted in a K of 1.5 nM and IC of 9.7 nM for the five-point Ub mutant, eliciting 27,500-fold and 5,500-fold enhancements in affinity and potency, respectively, as well as improved selectivity, without destabilizing the UbV structure. Our study highlights residue correlation and interaction networks in protein-protein interactions, and introduces an effective approach to design high-affinity protein binders for cell biology research and future therapeutics.

Citing Articles

PROTAC-induced protein structural dynamics in targeted protein degradation.

Wu K, Hung T, Chang C Elife. 2025; 13.

PMID: 40014381 PMC: 11867615. DOI: 10.7554/eLife.101127.


Pathway Specific Unbinding Free Energy Profiles of Ritonavir Dissociation from HIV-1 Protease.

Vig E, Sun J, Chang C Biochemistry. 2025; 64(4):940-952.

PMID: 39924810 PMC: 11844232. DOI: 10.1021/acs.biochem.4c00560.


DNA sequence and lesion-dependent mitochondrial transcription factor A (TFAM)-DNA-binding modulates DNA repair activities and products.

Urrutia K, Chen Y, Tang J, Hung T, Zhang G, Xu W Nucleic Acids Res. 2024; 52(22):14093-14111.

PMID: 39607700 PMC: 11662936. DOI: 10.1093/nar/gkae1144.

References
1.
Cao L, Coventry B, Goreshnik I, Huang B, Sheffler W, Park J . Design of protein-binding proteins from the target structure alone. Nature. 2022; 605(7910):551-560. PMC: 9117152. DOI: 10.1038/s41586-022-04654-9. View

2.
Harrigan J, Jacq X, Martin N, Jackson S . Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2017; 17(1):57-78. PMC: 7097658. DOI: 10.1038/nrd.2017.152. View

3.
Sun M, Seo M, Nim S, Corbi-Verge C, Kim P . Protein engineering by highly parallel screening of computationally designed variants. Sci Adv. 2016; 2(7):e1600692. PMC: 4956399. DOI: 10.1126/sciadv.1600692. View

4.
Lee H, Lei H, Santarsiero B, Gatuz J, Cao S, Rice A . Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. ACS Chem Biol. 2015; 10(6):1456-65. PMC: 4845099. DOI: 10.1021/cb500917m. View

5.
Morrow J, Lin H, Sun S, Zhang S . Targeting ubiquitination for cancer therapies. Future Med Chem. 2015; 7(17):2333-50. PMC: 4976843. DOI: 10.4155/fmc.15.148. View